Medindia

X

Stereotaxis Announces Fourth Quarter 2009 Earnings Release Date and Conference Call

Tuesday, February 9, 2010 Corporate News J E 4
Advertisement

ST. LOUIS, Feb. 9 /PRNewswire-FirstCall/ -- Stereotaxis, Inc. (Nasdaq: STXS) announced today that it will release its financial results for the fourth quarter ended December 31, 2009, on Thursday, February 25, 2010 before the market opens. The Company will host a conference call and webcast on Thursday, February 25, 2010 at 8:30 a.m. Eastern Time to discuss the Company's fourth quarter results and current corporate developments. The dial-in number for the conference call is 1-877-941-9205 for domestic participants and 1-480-629-9866 for international participants.

A taped replay of the conference call will also be available beginning approximately one hour after the call's conclusion and will be available for seven days.  This replay can be accessed by dialing 1-800-406-7325 for domestic callers and 303-590-3030 for international callers, both using passcode 4207018#.  The call will also be available on the Internet live and 90 days thereafter at the following URL:

http://www.videonewswire.com/event.asp?id=66045

About Stereotaxis

Stereotaxis designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital's interventional surgical suite to enhance the treatment of coronary artery disease and arrhythmias. The Stereotaxis System is designed to enable physicians to complete more complex interventional procedures by providing image guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. This is achieved using computer-controlled, externally applied magnetic fields that govern the motion of the working tip of the catheter or guidewire, resulting in improved navigation, shorter procedure time and reduced x-ray exposure. Stereotaxis' Odyssey™ solutions integrate and manage information from disparate information sources, eliminating the challenge of interacting simultaneously with many separate diagnostic systems, driving optimized workflow and improved productivity.  The core components of the Stereotaxis system have received regulatory clearance in the U.S., Europe and Canada.

SOURCE Stereotaxis, Inc.

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Cracking Cholesterol Confusion During American Hea...
S
Centene Corporation Reports 2009 Fourth Quarter an...